Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Urology

PUBLISHER: Grand View Research | PRODUCT CODE: 1363531

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1363531

Urolithiasis Management Devices Market Size, Share & Trends Analysis Report By Treatment Type (Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy), By End-use, By Region, And Segment Forecasts, 2023 - 2030

PUBLISHED:
PAGES: 115 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Urolithiasis Management Devices Market Growth & Trends:

The global urolithiasis management devices market was valued at USD 2.21 billion by 2030, according to a new report by Grand View Research, Inc.. It is expected to expand at a CAGR of 4.9% from 2023 to 2030. The alarming growth in the incidence rate of urinary stones, over the years, is responsible for the advancements in the treatment options. European Association of Urology states that it is one of the most common lifestyle disorders with a 10% prevalence rate and requires a systematic treatment approach.

Urolithiasis means formation of stones in the urinary system, mainly including the kidney, ureters, and the bladder. It is a major healthcare concern in the high end countries such as the U.S., Canada, and Germany with a recurrence rate of 50% in most of the cases. Urolithiasis can be managed with the help of lifestyle changes, controlled diet, or basic medication. However, various treatment approaches need to be adopted for the removal of large stones that cause severe pain. Depending upon the stone size, location in the body, and anatomical variations in the urogenital tract, invasive or noninvasive stone removal procedures are available. For instance, smaller stones can be tackled with external shock waves (extracorporeal shock wave lithotripsy), while larger stones can be removed through surgeries (intracorporeal lithotripsy or percutaneous nephrolithotomy).

Smaller stones generally do not require surgical interventions and can be cured with the help of medication and a healthy diet. However, larger stones necessitate different approaches for their elimination. Extracorporeal lithotripsy is one of the common treatments employed for stone elimination and held a majority market share in the year 2015. Intracorporeal lithotripsy treatments spot and reduce the stones to smaller pieces with the help of endoscopy. For the disintegration of stones, ultrasound or laser techniques are used to enable the passage of smaller fragments through the urinary system. Owing to the effective stone-free rate offered by intracorporeal lithotripsy, it is likely to be preferred as a treatment option during the forecast period.

Furthermore, percutaneous nephrolithotomy is a surgical approach deployed to eliminate larger stones where extracorporeal or intracorporeal lithotripsies prove to be ineffective and typically require a week's hospitalization.

Ambulatory surgical centers are gaining popularity over traditional hospital and clinic settings due to the time and cost saving benefits. As a result, this end-use segment is expected to record a lucrative growth rate during the forecast period. Introduction of novel surgical technologies, such as endoscopy and micro accessories including guidewires, scalpels, and baskets, to effectively expel stones from the urinary system in a short time has enhanced the overall acceptability of minimally invasive surgeries.

Urolithiasis Management Devices Market Report Highlights:

  • Urinary stones are highly prevalent worldwide with a 15% global target population and the recurrence rate of 50%. Men are more susceptible to developing renal stones than women.
  • The intracorporeal lithotripsy segment dominated the market and held the largest revenue share of 34.6% in 2022 and is expected to grow at the fastest CAGR of 6.8% over the forecast period. Intracorporeal lithotripsy involves the visualization of stones using an endoscope and their simultaneous disintegration into manageable fragments using lasers.
  • The upward trend in the adoption of sedentary lifestyle coupled with increased consumption of unhealthy food in the developed countries is responsible for the rising incidence of kidney stones. Ambulatory surgical service providers are expected to experience a surge in the treatment demand as a result of the unhealthy lifestyle changes, especially in the developed countries.
Show more
Product Code: GVR-1-68038-152-8

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Treatment type
    • 1.1.2. End use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Treatment type outlook
    • 2.2.2. End use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Urolithiasis Management Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Urolithiasis Management Devices Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Urolithiasis Management Devices: Treatment Type Estimates & Trend Analysis

  • 4.1. Urolithiasis Management Devices Market: Key Takeaways
  • 4.2. Urolithiasis Management Devices Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Extracorporeal Shock Wave Lithotripsy (ESWL)
    • 4.3.1. Extracorporeal shock wave lithotripsy (ESWL) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Intracorporeal Lithotripsy
    • 4.4.1. Intracorporeal lithotripsy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Percutaneous Nephrolithotomy
    • 4.5.1. Percutaneous nephrolithotomy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Other Treatments
    • 4.6.1. Other treatments market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Urolithiasis Management Devices: End Use Estimates & Trend Analysis

  • 5.1. Urolithiasis Management Devices Market: Key Takeaways
  • 5.2. Urolithiasis Management Devices Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Hospitals & Clinics
    • 5.3.1. Hospitals & clinics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Ambulatory Surgical Centers (ASCs)
    • 5.4.1. Ambulatory surgical centers (ASCs) market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Urolithiasis Management Devices Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Urolithiasis Management Devices Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. North America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. Europe market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. UK
      • 6.4.2.1. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. France
      • 6.4.4.1. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.9. Denmark
      • 6.4.9.1. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. China
      • 6.5.3.1. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. India
      • 6.5.4.1. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Australia
      • 6.5.5.1. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.7. South Korea
      • 6.5.7.1. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Latin America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Mexico
      • 6.6.3.1. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.4. Argentina
      • 6.6.4.1. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. MEA market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. South Africa
      • 6.7.3.1. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. Allengers
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Boston Scientific
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. BD
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Cook Medical
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. ConMed
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. DirexGroup
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Dornier MedTech
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Potent Optotronic
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. HealthTronics
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Karl Storz
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
    • 7.2.11. Lumenis
      • 7.2.11.1. Company overview
      • 7.2.11.2. Financial performance
      • 7.2.11.3. Product benchmarking
      • 7.2.11.4. Strategic initiatives
    • 7.2.12. Olympus
      • 7.2.12.1. Company overview
      • 7.2.12.2. Financial performance
      • 7.2.12.3. Product benchmarking
      • 7.2.12.4. Strategic initiatives
    • 7.2.13. Richard Wolf
      • 7.2.13.1. Company overview
      • 7.2.13.2. Financial performance
      • 7.2.13.3. Product benchmarking
      • 7.2.13.4. Strategic initiatives
    • 7.2.14. Siemens Healthcare
      • 7.2.14.1. Company overview
      • 7.2.14.2. Financial performance
      • 7.2.14.3. Product benchmarking
      • 7.2.14.4. Strategic initiatives
Show more
Product Code: GVR-1-68038-152-8

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 3 North America urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 4 North America urolithiasis management devices market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 6 U.S. urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 8 Canada urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Europe urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 10 Europe urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Europe urolithiasis management devices market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 13 Germany urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 14 UK urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 15 UK urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 16 France urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 17 France urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Italy urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 19 Italy urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Spain urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 21 Spain urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Sweden urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 23 Sweden urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Norway urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 25 Norway urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Denmark urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 27 Denmark urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific urolithiasis management devices market, by region, 2018 - 2030 (USD Million)
  • Table 31 China urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 32 China urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Japan urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 34 Japan urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 35 India urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 36 India urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Australia urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 38 Australia urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Thailand urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 40 Thailand urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 41 South Korea urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 42 South Korea urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Latin America urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 44 Latin America urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Latin America urolithiasis management devices market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 47 Brazil urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Mexico urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 49 Mexico urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Argentina urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 51 Argentina urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa urolithiasis management devices market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 56 South Africa urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 59 UAE urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 60 UAE urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 62 Kuwait urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Urolithiasis management devices: Market outlook
  • Fig. 8 Urolithiasis management devices: Competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Industry value chain analysis
  • Fig. 13 Urolithiasis management devices market driver impact
  • Fig. 14 Urolithiasis management devices market restraint impact
  • Fig. 15 Urolithiasis management devices market strategic initiatives analysis
  • Fig. 16 Urolithiasis management devices market: Treatment type movement analysis
  • Fig. 17 Urolithiasis management devices market: Treatment type outlook and key takeaways
  • Fig. 18 Extracorporeal shock wave lithotripsy (ESWL) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Intracorporeal lithotripsy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Percutaneous nephrolithotomy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Other treatments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Urolithiasis management devices market: End use movement analysis
  • Fig. 23 Urolithiasis management devices market: End use outlook and key takeaways
  • Fig. 24 Hospitals & clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Ambulatory surgical centers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Global urolithiasis management devices market: Regional movement analysis
  • Fig. 27 Global urolithiasis management devices market: Regional outlook and key takeaways
  • Fig. 28 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!